Cenetron Announces Launch of GlobeSync Pharma Data Portal

Share Article

WEB-based reporting tool for pharma clients allows real-time view of laboratory data and customized study-wide reports.

The launch of GlobeSync is another step in providing a seamless flow of high quality data to our pharmaceutical clients

Cenetron Diagnostics, Ltd., a leading Central Laboratory that specializes in molecular diagnostics, announced today that it has implemented GlobeSync, a advanced WEB-based data portal for global clinical trials.

GlobeSync allows pharma study managers, study monitors, and investigators secure, real-time access to laboratory results and to a variety of customized reports. GlobeSyncTM is directly linked to Cenetron's highly specialized version of its STARLIMS® Laboratory Information Management System. Data blinding and report access limitations by user roles are easily programmed for each individual clinical trial.

The combination of the reporting features, advanced security, data integrity, and audit trail capabilities of STARLIMS and GlobeSync enable Cenetron to meet the stringent requirements of its pharmaceutical clients--for timely reports, for data transfers of absolute quality and accuracy, for full compliance with FDA 21 CFR part 11 guidelines, and for real-time reports ranging from individual subject results to study-wide trend analysis.

"The launch of GlobeSync is another step in providing a seamless flow of high quality data to our pharmaceutical clients," said Dwight DuBois, President of Cenetron. "We are able to custom create visually appealing, intuitive reports, that provide managers an accurate, timely snapshot of patient screening and enrollment, laboratory testing, and a clear view of individual subject and study-wide results. GlobeSync has been enthusiastically received by our clients, who have found the system easy to use, and a very valuable management tool."

About Cenetron
Cenetron Diagnostics is a premiere provider of molecular laboratory services, providing support for anti-viral and oncology drug development programs, and pharmacogenomics. Founded in 1995, Cenetron has supported pivotal global trials in North and South America, Europe, Africa and the Pacific Rim. Cenetron's client list includes leading pharmaceutical clients in the United States and Europe. For further information visit http://www.cenetron.com

Contact:
Jason Guin
Cenetron Diagnostics
jguin @ cenetron.com
+1 512.439.2000 Ext. 117

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dwight DuBois
Visit website